SCHEMBL26484667

SCHEMBL26484667

COc1cc(C(C)C)ccc1N1CCC(N2CC2)CC1

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.46
KDM4E B2RXH2 4/20 0.45
ALDH1A1 P00352 3/20 0.45
HTT P42858 1/20 0.45
HTR1A P08908 1/20 0.44
ADRA1D P25100 1/20 0.44
ADRA1A P35348 1/20 0.44
ADRA1B P35368 1/20 0.44
FGFR3 P22607 7/20 0.44
DRD2 P14416 1/20 0.43
DRD3 P35462 1/20 0.43
FGFR1 P11362 1/20 0.42
FGFR2 P21802 1/20 0.42
FGFR4 P22455 1/20 0.42
KDR P35968 1/20 0.42
KCNH2 Q12809 1/20 0.42
ABCB1 P08183 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26406701 0.94 ALDH1A1 (0.42) SMN1; SMN2KDM4EALDH1A1HTTHTR1A
SCHEMBL17660614 0.93 CCR4 (0.44) SMN1; SMN2KDM4EALDH1A1ABCB1
SCHEMBL17306128 0.92 ALDH1A1 (0.54) SMN1; SMN2KDM4EALDH1A1HTTHTR1A
SCHEMBL20458023 0.91 KDM2B (0.47) SMN1; SMN2KDM4EALDH1A1HTTFGFR3
SCHEMBL26484763 0.85 ALDH1A1 (0.43) ALDH1A1HTR1ADRD2DRD3
SCHEMBL17660577 0.85 DRD2 (0.43) SMN1; SMN2KDM4EALDH1A1HTR1AADRA1D
SCHEMBL24123770 0.84 ALDH1A1 (0.41) SMN1; SMN2ALDH1A1HTTHTR1AADRA1A
SCHEMBL12354671 0.84 ACACB (0.43) KDM4EALDH1A1HTR1A
SCHEMBL26484765 0.83 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1HTTHTR1A
SCHEMBL26484766 0.82 ADRA1D (0.43) ADRA1DADRA1AADRA1BDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023075479-A1 NOVEL THIENO[2,3-D]PYRIMIDINE DERIVATIVE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT OF CANCER OR AUTOIMMUNE DISEASE COMPRISING SAME AS ACTIVE INGREDIENT 재단법인 대구경북첨단의료산업진흥재단 2023-05-04 WO disclosed